X4 Pharmaceuticals, Inc. (XFOR)
NASDAQ·Healthcare·Biotechnology
$4.01
+3.35%
Mkt Cap $48.03M
Analyst Ratings
No recent rating data.
Price Target (9 analysts)
$12.00
Range $12.00 – $12.00
Implied Upside
+199.3%
Consensus $12.00 vs current $4.01
NASDAQ·Healthcare·Biotechnology
$4.01
+3.35%
Mkt Cap $48.03M
No recent rating data.
Price Target (9 analysts)
$12.00
Range $12.00 – $12.00
+199.3%
Consensus $12.00 vs current $4.01